(Q64639724)

English

A Study of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Phase III, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of MK-3102 Versus Placebo in Subjects With Type 2 Diabetes Mellitus With Moderate or Severe Chronic Kidney Disease or Kidney Failure on Dialysis Who Have Inadequate Glycemic Control. (English)

0 references

medical condition

diabetes

0 references

start time

2 October 2012

0 references

end time

19 January 2016

0 references

number of participants

213